FDA Inspection 1219451 — Institute for Reproductive Medicine and Science at Saint Barnabas, P.A.

Institute for Reproductive Medicine and Science at Saint Barnabas, P.A. — FEI 3001047110

The FDA completed an inspection of Institute for Reproductive Medicine and Science at Saint Barnabas, P.A. on September 27, 2023 in Livingston, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 27, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Livingston, NJ (United States)